Article ID Journal Published Year Pages File Type
5825771 Clinical Therapeutics 2012 16 Pages PDF
Abstract
When current therapy is not adequate to obtain glycemic control, acarbose could be an option as monotherapy and as an add-on to other antidiabetic drug treatment, especially when postprandial hyperglycemia is the main concern. Long-term studies are needed to determine whether the effects observed with acarbose use are maintained over the years.
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Authors
, , ,